Smarter oncology second opinion — AI-powered, expert-reviewed, using your existing NGS report.
Read More
𝐂𝐚𝐧 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐭𝐫𝐮𝐥𝐲 𝐛𝐞 𝐞𝐪𝐮𝐢𝐭𝐚𝐛𝐥𝐞? In this 10-minute talk, Dr. Petak explains why today’s cutting-edge molecular diagnostics often fail to reach the patients who need them most and how Genomate’s computational reasoning approach is changing that by standardizing treatment decisions across cancer centers, from Boston to Bangladesh.
.avif)
